2Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients:A national study. Am J kidney Dis, 1998, 31: 607-617.
4Garred LJ, Barichello DL, Canaud BC, et al. Simple equations for protein catabolic rate determination from pre dialysis and post dialysis blood urea nitrogen. ASAIO J, 1995, 41: 889-895.
5Raggi P. Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients. Am J Kidney Dis,2001, 37(1 Suppl 2): s62-s65.
6Block G, Port FK. Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial,2003, 16: 140-147.
7Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis,2000, 35: 1226-1237.
8Locatelli F, Cannata-Andia JB, Drueke TB, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant, 2002, 17: 723-731.
9Lim VS, Flanigan MJ, Fangrnan J. Effect of hematocrit on solute removal during high efficiency hemodialysis. Kidney Int,1990, 37: 1557-1562.
10Winchester JF, Rotellar C, Goggins M, et al. Calcium and phosphate balance in dialysis patients. Kidney Int Suppl, 1993, 41:S174-S178.
